Impacts of IVDR Implementation on Patient Access to Clinical Trials Online

The recently implemented In Vitro Diagnostics Regulation (IVDR) establishes a new regulatory framework for in vitro diagnostics in the EU to better ensure test accuracy and patient safety. However, current challenges to the implementation of IVDR are leading to delays in clinical trial initiation and posing hurdles to patients’ access to trials throughout Europe.

On February 7, 2023 at 11:00am ET (GMT -5:00), the LUNGevity Foundation will host a public webinar for stakeholders to learn more about the issue in depth and to contribute to a sign-on letter to the European Commission pressing for solutions to ensure patient access to clinical trials is maintained during the implementation of IVDR.